CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 390,554	$ 648,719
Marketable securities	213,694	251,761
Accounts receivable - trade, net	1,071,665	739,379
Accounts Receivable from Sanofi	197,693	111,510
Accounts receivable from Bayer HealthCare	125,767	125,483
Inventories	171,266	128,861
Deferred tax assets	69,603	46,179
Prepaid expenses and other current assets	43,099	79,046
Total current assets	2,283,341	2,130,938
Marketable securities	589,595	460,154
Property, plant, and equipment, at cost, net of accumulated depreciation and amortization	1,326,112	974,309
Deferred tax assets	323,784	269,237
Other assets	4,138	3,034
Total assets	4,526,970	3,837,672
Current liabilities:
Accounts payable and accrued expenses	529,505	483,489
Deferred revenue from Sanofi, current portion	18,026	15,927
Deferred revenue - other, current portion	51,720	58,098
Other Liabilities, Current	2,291	97,146
Total current liabilities	601,542	654,660
Deferred revenue from Sanofi	46,095	62,819
Deferred Revenue - other	76,748	72,430
Facility lease obligations	357,687	310,938
Convertible senior notes	30,360	146,773
Other long-term liabilities	76,080	39,801
Total liabilities	1,188,512	1,287,421
Stockholders' equity:
Preferred Stock	0	0
Additional paid-in capital	3,118,969	2,450,782
Retained earnings	487,308	216,644
Accumulated other comprehensive income	19,153	52,251
Treasury stock	(287,079)	(169,530)
Total stockholders' equity	3,338,458	2,550,251
Total liabilities and stockholders' equity	4,526,970	3,837,672
Class A Stock
Stockholders' equity:
Common stock	2	2
Common Stock
Stockholders' equity:
Common stock	$ 105	$ 102